XAIR
$5.10
Beyond Air
($.03)
(.58%)
XAIR
Earnings Whisper ®
N/A
1st Quarter June 2021
Consensus:  ($0.19)
Revenue:  $0.07 Mil
Thursday
Sep 9
4:05 PM ET
Score
Grade
Tweet Share Watch
Tweet Share Watch

What do you expect when XAIR reports earnings?
Beat
Meet
Miss

Where is XAIR's stock price going from here?
Up
Flat
Down
Stock chart of XAIR
Analysts
Summary of analysts' recommendations for XAIR
Score
Grade
Pivots
Resistance
$5.36
$5.28
$5.19

$5.11

Support
$5.02
$4.94
$4.85
Tweet
Growth
Description
Beyond Air Inc. is a clinical-stage medical device and biopharmaceutical company. It is engaged in developing a Nitric Oxide Generator and Delivery System. The company's principal product is AirNOvent which is in clinical stage. Beyond Air Inc., formerly known as AIT Therapeutics Inc., is based in Garden City, New York.